The global Oligonucleotide Drug Delivery market size was estimated at USD 63950 million in 2023 and is projected to reach USD 88684.83 million by 2032, exhibiting a CAGR of 3.70% during the forecast period.
North America Oligonucleotide Drug Delivery market size was estimated at USD 17737.25 million in 2023, at a CAGR of 3.17% during the forecast period of 2025 through 2032.
Report Overview
Oligonucleotides can be used to modulate gene expression via a range of processes including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation, non-coding RNA inhibition, gene activation and programmed gene editing.
This report provides a deep insight into the global Oligonucleotide Drug Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotide Drug Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotide Drug Delivery market in any manner.
Global Oligonucleotide Drug Delivery Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Sarepta Therapeutics
- Ionis Pharmaceuticals
- Alnylam
- Biogen
- Nippon Shinyaku
- Sobi
- Novartis
- BioNTech
- Pfizer
- Moderna Therapeutics
- Jazz Pharmaceuticals
- CureVac
- Regulus Therapeutics
- ProQR
- Secarna
- MiNA Therapeutics
- Sylentis
- Arrowhead
- Silence Therapeutics
- Dicerna
Market Segmentation (by Type)
- Antisense Oligonucleotides (ASO)
- siRNA
- mRNA
Market Segmentation (by Application)
- Neuromuscular Diseases
- hATTR
- COVID-19
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oligonucleotide Drug Delivery Market
- Overview of the regional outlook of the Oligonucleotide Drug Delivery Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oligonucleotide Drug Delivery
1.2 Key Market Segments
1.2.1 Oligonucleotide Drug Delivery Segment by Type
1.2.2 Oligonucleotide Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oligonucleotide Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Oligonucleotide Drug Delivery Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oligonucleotide Drug Delivery Market Competitive Landscape
3.1 Global Oligonucleotide Drug Delivery Sales by Manufacturers (2019-2025)
3.2 Global Oligonucleotide Drug Delivery Revenue Market Share by Manufacturers (2019-2025)
3.3 Oligonucleotide Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oligonucleotide Drug Delivery Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Oligonucleotide Drug Delivery Sales Sites, Area Served, Product Type
3.6 Oligonucleotide Drug Delivery Market Competitive Situation and Trends
3.6.1 Oligonucleotide Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oligonucleotide Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oligonucleotide Drug Delivery Industry Chain Analysis
4.1 Oligonucleotide Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oligonucleotide Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oligonucleotide Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Drug Delivery Sales Market Share by Type (2019-2025)
6.3 Global Oligonucleotide Drug Delivery Market Size Market Share by Type (2019-2025)
6.4 Global Oligonucleotide Drug Delivery Price by Type (2019-2025)
7 Oligonucleotide Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Drug Delivery Market Sales by Application (2019-2025)
7.3 Global Oligonucleotide Drug Delivery Market Size (M USD) by Application (2019-2025)
7.4 Global Oligonucleotide Drug Delivery Sales Growth Rate by Application (2019-2025)
8 Oligonucleotide Drug Delivery Market Consumption by Region
8.1 Global Oligonucleotide Drug Delivery Sales by Region
8.1.1 Global Oligonucleotide Drug Delivery Sales by Region
8.1.2 Global Oligonucleotide Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Oligonucleotide Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oligonucleotide Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oligonucleotide Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oligonucleotide Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oligonucleotide Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Oligonucleotide Drug Delivery Market Production by Region
9.1 Global Production of Oligonucleotide Drug Delivery by Region (2019-2025)
9.2 Global Oligonucleotide Drug Delivery Revenue Market Share by Region (2019-2025)
9.3 Global Oligonucleotide Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Oligonucleotide Drug Delivery Production
9.4.1 North America Oligonucleotide Drug Delivery Production Growth Rate (2019-2025)
9.4.2 North America Oligonucleotide Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Oligonucleotide Drug Delivery Production
9.5.1 Europe Oligonucleotide Drug Delivery Production Growth Rate (2019-2025)
9.5.2 Europe Oligonucleotide Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Oligonucleotide Drug Delivery Production (2019-2025)
9.6.1 Japan Oligonucleotide Drug Delivery Production Growth Rate (2019-2025)
9.6.2 Japan Oligonucleotide Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Oligonucleotide Drug Delivery Production (2019-2025)
9.7.1 China Oligonucleotide Drug Delivery Production Growth Rate (2019-2025)
9.7.2 China Oligonucleotide Drug Delivery Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Sarepta Therapeutics
10.1.1 Sarepta Therapeutics Oligonucleotide Drug Delivery Basic Information
10.1.2 Sarepta Therapeutics Oligonucleotide Drug Delivery Product Overview
10.1.3 Sarepta Therapeutics Oligonucleotide Drug Delivery Product Market Performance
10.1.4 Sarepta Therapeutics Business Overview
10.1.5 Sarepta Therapeutics Oligonucleotide Drug Delivery SWOT Analysis
10.1.6 Sarepta Therapeutics Recent Developments
10.2 Ionis Pharmaceuticals
10.2.1 Ionis Pharmaceuticals Oligonucleotide Drug Delivery Basic Information
10.2.2 Ionis Pharmaceuticals Oligonucleotide Drug Delivery Product Overview
10.2.3 Ionis Pharmaceuticals Oligonucleotide Drug Delivery Product Market Performance
10.2.4 Ionis Pharmaceuticals Business Overview
10.2.5 Ionis Pharmaceuticals Oligonucleotide Drug Delivery SWOT Analysis
10.2.6 Ionis Pharmaceuticals Recent Developments
10.3 Alnylam
10.3.1 Alnylam Oligonucleotide Drug Delivery Basic Information
10.3.2 Alnylam Oligonucleotide Drug Delivery Product Overview
10.3.3 Alnylam Oligonucleotide Drug Delivery Product Market Performance
10.3.4 Alnylam Oligonucleotide Drug Delivery SWOT Analysis
10.3.5 Alnylam Business Overview
10.3.6 Alnylam Recent Developments
10.4 Biogen
10.4.1 Biogen Oligonucleotide Drug Delivery Basic Information
10.4.2 Biogen Oligonucleotide Drug Delivery Product Overview
10.4.3 Biogen Oligonucleotide Drug Delivery Product Market Performance
10.4.4 Biogen Business Overview
10.4.5 Biogen Recent Developments
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Oligonucleotide Drug Delivery Basic Information
10.5.2 Nippon Shinyaku Oligonucleotide Drug Delivery Product Overview
10.5.3 Nippon Shinyaku Oligonucleotide Drug Delivery Product Market Performance
10.5.4 Nippon Shinyaku Business Overview
10.5.5 Nippon Shinyaku Recent Developments
10.6 Sobi
10.6.1 Sobi Oligonucleotide Drug Delivery Basic Information
10.6.2 Sobi Oligonucleotide Drug Delivery Product Overview
10.6.3 Sobi Oligonucleotide Drug Delivery Product Market Performance
10.6.4 Sobi Business Overview
10.6.5 Sobi Recent Developments
10.7 Novartis
10.7.1 Novartis Oligonucleotide Drug Delivery Basic Information
10.7.2 Novartis Oligonucleotide Drug Delivery Product Overview
10.7.3 Novartis Oligonucleotide Drug Delivery Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 BioNTech
10.8.1 BioNTech Oligonucleotide Drug Delivery Basic Information
10.8.2 BioNTech Oligonucleotide Drug Delivery Product Overview
10.8.3 BioNTech Oligonucleotide Drug Delivery Product Market Performance
10.8.4 BioNTech Business Overview
10.8.5 BioNTech Recent Developments
10.9 Pfizer
10.9.1 Pfizer Oligonucleotide Drug Delivery Basic Information
10.9.2 Pfizer Oligonucleotide Drug Delivery Product Overview
10.9.3 Pfizer Oligonucleotide Drug Delivery Product Market Performance
10.9.4 Pfizer Business Overview
10.9.5 Pfizer Recent Developments
10.10 Moderna Therapeutics
10.10.1 Moderna Therapeutics Oligonucleotide Drug Delivery Basic Information
10.10.2 Moderna Therapeutics Oligonucleotide Drug Delivery Product Overview
10.10.3 Moderna Therapeutics Oligonucleotide Drug Delivery Product Market Performance
10.10.4 Moderna Therapeutics Business Overview
10.10.5 Moderna Therapeutics Recent Developments
10.11 Jazz Pharmaceuticals
10.11.1 Jazz Pharmaceuticals Oligonucleotide Drug Delivery Basic Information
10.11.2 Jazz Pharmaceuticals Oligonucleotide Drug Delivery Product Overview
10.11.3 Jazz Pharmaceuticals Oligonucleotide Drug Delivery Product Market Performance
10.11.4 Jazz Pharmaceuticals Business Overview
10.11.5 Jazz Pharmaceuticals Recent Developments
10.12 CureVac
10.12.1 CureVac Oligonucleotide Drug Delivery Basic Information
10.12.2 CureVac Oligonucleotide Drug Delivery Product Overview
10.12.3 CureVac Oligonucleotide Drug Delivery Product Market Performance
10.12.4 CureVac Business Overview
10.12.5 CureVac Recent Developments
10.13 Regulus Therapeutics
10.13.1 Regulus Therapeutics Oligonucleotide Drug Delivery Basic Information
10.13.2 Regulus Therapeutics Oligonucleotide Drug Delivery Product Overview
10.13.3 Regulus Therapeutics Oligonucleotide Drug Delivery Product Market Performance
10.13.4 Regulus Therapeutics Business Overview
10.13.5 Regulus Therapeutics Recent Developments
10.14 ProQR
10.14.1 ProQR Oligonucleotide Drug Delivery Basic Information
10.14.2 ProQR Oligonucleotide Drug Delivery Product Overview
10.14.3 ProQR Oligonucleotide Drug Delivery Product Market Performance
10.14.4 ProQR Business Overview
10.14.5 ProQR Recent Developments
10.15 Secarna
10.15.1 Secarna Oligonucleotide Drug Delivery Basic Information
10.15.2 Secarna Oligonucleotide Drug Delivery Product Overview
10.15.3 Secarna Oligonucleotide Drug Delivery Product Market Performance
10.15.4 Secarna Business Overview
10.15.5 Secarna Recent Developments
10.16 MiNA Therapeutics
10.16.1 MiNA Therapeutics Oligonucleotide Drug Delivery Basic Information
10.16.2 MiNA Therapeutics Oligonucleotide Drug Delivery Product Overview
10.16.3 MiNA Therapeutics Oligonucleotide Drug Delivery Product Market Performance
10.16.4 MiNA Therapeutics Business Overview
10.16.5 MiNA Therapeutics Recent Developments
10.17 Sylentis
10.17.1 Sylentis Oligonucleotide Drug Delivery Basic Information
10.17.2 Sylentis Oligonucleotide Drug Delivery Product Overview
10.17.3 Sylentis Oligonucleotide Drug Delivery Product Market Performance
10.17.4 Sylentis Business Overview
10.17.5 Sylentis Recent Developments
10.18 Arrowhead
10.18.1 Arrowhead Oligonucleotide Drug Delivery Basic Information
10.18.2 Arrowhead Oligonucleotide Drug Delivery Product Overview
10.18.3 Arrowhead Oligonucleotide Drug Delivery Product Market Performance
10.18.4 Arrowhead Business Overview
10.18.5 Arrowhead Recent Developments
10.19 Silence Therapeutics
10.19.1 Silence Therapeutics Oligonucleotide Drug Delivery Basic Information
10.19.2 Silence Therapeutics Oligonucleotide Drug Delivery Product Overview
10.19.3 Silence Therapeutics Oligonucleotide Drug Delivery Product Market Performance
10.19.4 Silence Therapeutics Business Overview
10.19.5 Silence Therapeutics Recent Developments
10.20 Dicerna
10.20.1 Dicerna Oligonucleotide Drug Delivery Basic Information
10.20.2 Dicerna Oligonucleotide Drug Delivery Product Overview
10.20.3 Dicerna Oligonucleotide Drug Delivery Product Market Performance
10.20.4 Dicerna Business Overview
10.20.5 Dicerna Recent Developments
11 Oligonucleotide Drug Delivery Market Forecast by Region
11.1 Global Oligonucleotide Drug Delivery Market Size Forecast
11.2 Global Oligonucleotide Drug Delivery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide Drug Delivery Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide Drug Delivery Market Size Forecast by Region
11.2.4 South America Oligonucleotide Drug Delivery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Oligonucleotide Drug Delivery by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Oligonucleotide Drug Delivery Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Oligonucleotide Drug Delivery by Type (2025-2032)
12.1.2 Global Oligonucleotide Drug Delivery Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Oligonucleotide Drug Delivery by Type (2025-2032)
12.2 Global Oligonucleotide Drug Delivery Market Forecast by Application (2025-2032)
12.2.1 Global Oligonucleotide Drug Delivery Sales (K MT) Forecast by Application
12.2.2 Global Oligonucleotide Drug Delivery Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oligonucleotide Drug Delivery Market Size Comparison by Region (M USD)
Table 5. Global Oligonucleotide Drug Delivery Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Oligonucleotide Drug Delivery Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Oligonucleotide Drug Delivery Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Oligonucleotide Drug Delivery Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Drug Delivery as of 2022)
Table 10. Global Market Oligonucleotide Drug Delivery Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Oligonucleotide Drug Delivery Sales Sites and Area Served
Table 12. Manufacturers Oligonucleotide Drug Delivery Product Type
Table 13. Global Oligonucleotide Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oligonucleotide Drug Delivery
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oligonucleotide Drug Delivery Market Challenges
Table 22. Global Oligonucleotide Drug Delivery Sales by Type (K MT)
Table 23. Global Oligonucleotide Drug Delivery Market Size by Type (M USD)
Table 24. Global Oligonucleotide Drug Delivery Sales (K MT) by Type (2019-2025)
Table 25. Global Oligonucleotide Drug Delivery Sales Market Share by Type (2019-2025)
Table 26. Global Oligonucleotide Drug Delivery Market Size (M USD) by Type (2019-2025)
Table 27. Global Oligonucleotide Drug Delivery Market Size Share by Type (2019-2025)
Table 28. Global Oligonucleotide Drug Delivery Price (USD/MT) by Type (2019-2025)
Table 29. Global Oligonucleotide Drug Delivery Sales (K MT) by Application
Table 30. Global Oligonucleotide Drug Delivery Market Size by Application
Table 31. Global Oligonucleotide Drug Delivery Sales by Application (2019-2025) & (K MT)
Table 32. Global Oligonucleotide Drug Delivery Sales Market Share by Application (2019-2025)
Table 33. Global Oligonucleotide Drug Delivery Sales by Application (2019-2025) & (M USD)
Table 34. Global Oligonucleotide Drug Delivery Market Share by Application (2019-2025)
Table 35. Global Oligonucleotide Drug Delivery Sales Growth Rate by Application (2019-2025)
Table 36. Global Oligonucleotide Drug Delivery Sales by Region (2019-2025) & (K MT)
Table 37. Global Oligonucleotide Drug Delivery Sales Market Share by Region (2019-2025)
Table 38. North America Oligonucleotide Drug Delivery Sales by Country (2019-2025) & (K MT)
Table 39. Europe Oligonucleotide Drug Delivery Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Oligonucleotide Drug Delivery Sales by Region (2019-2025) & (K MT)
Table 41. South America Oligonucleotide Drug Delivery Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Oligonucleotide Drug Delivery Sales by Region (2019-2025) & (K MT)
Table 43. Global Oligonucleotide Drug Delivery Production (K MT) by Region (2019-2025)
Table 44. Global Oligonucleotide Drug Delivery Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Oligonucleotide Drug Delivery Revenue Market Share by Region (2019-2025)
Table 46. Global Oligonucleotide Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Oligonucleotide Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Oligonucleotide Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Oligonucleotide Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Oligonucleotide Drug Delivery Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Sarepta Therapeutics Oligonucleotide Drug Delivery Basic Information
Table 52. Sarepta Therapeutics Oligonucleotide Drug Delivery Product Overview
Table 53. Sarepta Therapeutics Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Sarepta Therapeutics Business Overview
Table 55. Sarepta Therapeutics Oligonucleotide Drug Delivery SWOT Analysis
Table 56. Sarepta Therapeutics Recent Developments
Table 57. Ionis Pharmaceuticals Oligonucleotide Drug Delivery Basic Information
Table 58. Ionis Pharmaceuticals Oligonucleotide Drug Delivery Product Overview
Table 59. Ionis Pharmaceuticals Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Ionis Pharmaceuticals Business Overview
Table 61. Ionis Pharmaceuticals Oligonucleotide Drug Delivery SWOT Analysis
Table 62. Ionis Pharmaceuticals Recent Developments
Table 63. Alnylam Oligonucleotide Drug Delivery Basic Information
Table 64. Alnylam Oligonucleotide Drug Delivery Product Overview
Table 65. Alnylam Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Alnylam Oligonucleotide Drug Delivery SWOT Analysis
Table 67. Alnylam Business Overview
Table 68. Alnylam Recent Developments
Table 69. Biogen Oligonucleotide Drug Delivery Basic Information
Table 70. Biogen Oligonucleotide Drug Delivery Product Overview
Table 71. Biogen Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Biogen Business Overview
Table 73. Biogen Recent Developments
Table 74. Nippon Shinyaku Oligonucleotide Drug Delivery Basic Information
Table 75. Nippon Shinyaku Oligonucleotide Drug Delivery Product Overview
Table 76. Nippon Shinyaku Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Nippon Shinyaku Business Overview
Table 78. Nippon Shinyaku Recent Developments
Table 79. Sobi Oligonucleotide Drug Delivery Basic Information
Table 80. Sobi Oligonucleotide Drug Delivery Product Overview
Table 81. Sobi Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Sobi Business Overview
Table 83. Sobi Recent Developments
Table 84. Novartis Oligonucleotide Drug Delivery Basic Information
Table 85. Novartis Oligonucleotide Drug Delivery Product Overview
Table 86. Novartis Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Novartis Business Overview
Table 88. Novartis Recent Developments
Table 89. BioNTech Oligonucleotide Drug Delivery Basic Information
Table 90. BioNTech Oligonucleotide Drug Delivery Product Overview
Table 91. BioNTech Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. BioNTech Business Overview
Table 93. BioNTech Recent Developments
Table 94. Pfizer Oligonucleotide Drug Delivery Basic Information
Table 95. Pfizer Oligonucleotide Drug Delivery Product Overview
Table 96. Pfizer Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Pfizer Business Overview
Table 98. Pfizer Recent Developments
Table 99. Moderna Therapeutics Oligonucleotide Drug Delivery Basic Information
Table 100. Moderna Therapeutics Oligonucleotide Drug Delivery Product Overview
Table 101. Moderna Therapeutics Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Moderna Therapeutics Business Overview
Table 103. Moderna Therapeutics Recent Developments
Table 104. Jazz Pharmaceuticals Oligonucleotide Drug Delivery Basic Information
Table 105. Jazz Pharmaceuticals Oligonucleotide Drug Delivery Product Overview
Table 106. Jazz Pharmaceuticals Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Jazz Pharmaceuticals Business Overview
Table 108. Jazz Pharmaceuticals Recent Developments
Table 109. CureVac Oligonucleotide Drug Delivery Basic Information
Table 110. CureVac Oligonucleotide Drug Delivery Product Overview
Table 111. CureVac Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. CureVac Business Overview
Table 113. CureVac Recent Developments
Table 114. Regulus Therapeutics Oligonucleotide Drug Delivery Basic Information
Table 115. Regulus Therapeutics Oligonucleotide Drug Delivery Product Overview
Table 116. Regulus Therapeutics Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Regulus Therapeutics Business Overview
Table 118. Regulus Therapeutics Recent Developments
Table 119. ProQR Oligonucleotide Drug Delivery Basic Information
Table 120. ProQR Oligonucleotide Drug Delivery Product Overview
Table 121. ProQR Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. ProQR Business Overview
Table 123. ProQR Recent Developments
Table 124. Secarna Oligonucleotide Drug Delivery Basic Information
Table 125. Secarna Oligonucleotide Drug Delivery Product Overview
Table 126. Secarna Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Secarna Business Overview
Table 128. Secarna Recent Developments
Table 129. MiNA Therapeutics Oligonucleotide Drug Delivery Basic Information
Table 130. MiNA Therapeutics Oligonucleotide Drug Delivery Product Overview
Table 131. MiNA Therapeutics Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. MiNA Therapeutics Business Overview
Table 133. MiNA Therapeutics Recent Developments
Table 134. Sylentis Oligonucleotide Drug Delivery Basic Information
Table 135. Sylentis Oligonucleotide Drug Delivery Product Overview
Table 136. Sylentis Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Sylentis Business Overview
Table 138. Sylentis Recent Developments
Table 139. Arrowhead Oligonucleotide Drug Delivery Basic Information
Table 140. Arrowhead Oligonucleotide Drug Delivery Product Overview
Table 141. Arrowhead Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Arrowhead Business Overview
Table 143. Arrowhead Recent Developments
Table 144. Silence Therapeutics Oligonucleotide Drug Delivery Basic Information
Table 145. Silence Therapeutics Oligonucleotide Drug Delivery Product Overview
Table 146. Silence Therapeutics Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Silence Therapeutics Business Overview
Table 148. Silence Therapeutics Recent Developments
Table 149. Dicerna Oligonucleotide Drug Delivery Basic Information
Table 150. Dicerna Oligonucleotide Drug Delivery Product Overview
Table 151. Dicerna Oligonucleotide Drug Delivery Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Dicerna Business Overview
Table 153. Dicerna Recent Developments
Table 154. Global Oligonucleotide Drug Delivery Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Oligonucleotide Drug Delivery Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Oligonucleotide Drug Delivery Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Oligonucleotide Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Oligonucleotide Drug Delivery Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Oligonucleotide Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Oligonucleotide Drug Delivery Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Oligonucleotide Drug Delivery Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Oligonucleotide Drug Delivery Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Oligonucleotide Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Oligonucleotide Drug Delivery Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Oligonucleotide Drug Delivery Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Oligonucleotide Drug Delivery Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Oligonucleotide Drug Delivery Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Oligonucleotide Drug Delivery Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Oligonucleotide Drug Delivery Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Oligonucleotide Drug Delivery Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Oligonucleotide Drug Delivery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oligonucleotide Drug Delivery Market Size (M USD), 2019-2032
Figure 5. Global Oligonucleotide Drug Delivery Market Size (M USD) (2019-2032)
Figure 6. Global Oligonucleotide Drug Delivery Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oligonucleotide Drug Delivery Market Size by Country (M USD)
Figure 11. Oligonucleotide Drug Delivery Sales Share by Manufacturers in 2023
Figure 12. Global Oligonucleotide Drug Delivery Revenue Share by Manufacturers in 2023
Figure 13. Oligonucleotide Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oligonucleotide Drug Delivery Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oligonucleotide Drug Delivery Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oligonucleotide Drug Delivery Market Share by Type
Figure 18. Sales Market Share of Oligonucleotide Drug Delivery by Type (2019-2025)
Figure 19. Sales Market Share of Oligonucleotide Drug Delivery by Type in 2023
Figure 20. Market Size Share of Oligonucleotide Drug Delivery by Type (2019-2025)
Figure 21. Market Size Market Share of Oligonucleotide Drug Delivery by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oligonucleotide Drug Delivery Market Share by Application
Figure 24. Global Oligonucleotide Drug Delivery Sales Market Share by Application (2019-2025)
Figure 25. Global Oligonucleotide Drug Delivery Sales Market Share by Application in 2023
Figure 26. Global Oligonucleotide Drug Delivery Market Share by Application (2019-2025)
Figure 27. Global Oligonucleotide Drug Delivery Market Share by Application in 2023
Figure 28. Global Oligonucleotide Drug Delivery Sales Growth Rate by Application (2019-2025)
Figure 29. Global Oligonucleotide Drug Delivery Sales Market Share by Region (2019-2025)
Figure 30. North America Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Oligonucleotide Drug Delivery Sales Market Share by Country in 2023
Figure 32. U.S. Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Oligonucleotide Drug Delivery Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Oligonucleotide Drug Delivery Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Oligonucleotide Drug Delivery Sales Market Share by Country in 2023
Figure 37. Germany Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Oligonucleotide Drug Delivery Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Oligonucleotide Drug Delivery Sales Market Share by Region in 2023
Figure 44. China Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Oligonucleotide Drug Delivery Sales and Growth Rate (K MT)
Figure 50. South America Oligonucleotide Drug Delivery Sales Market Share by Country in 2023
Figure 51. Brazil Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Oligonucleotide Drug Delivery Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Oligonucleotide Drug Delivery Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Oligonucleotide Drug Delivery Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Oligonucleotide Drug Delivery Production Market Share by Region (2019-2025)
Figure 62. North America Oligonucleotide Drug Delivery Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Oligonucleotide Drug Delivery Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Oligonucleotide Drug Delivery Production (K MT) Growth Rate (2019-2025)
Figure 65. China Oligonucleotide Drug Delivery Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Oligonucleotide Drug Delivery Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Oligonucleotide Drug Delivery Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Oligonucleotide Drug Delivery Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Oligonucleotide Drug Delivery Market Share Forecast by Type (2025-2032)
Figure 70. Global Oligonucleotide Drug Delivery Sales Forecast by Application (2025-2032)
Figure 71. Global Oligonucleotide Drug Delivery Market Share Forecast by Application (2025-2032)
